683 Capital Management’s Tobira Therapeutics, Inc. Common Stock TBRA Stock Holding History

683 Capital Management’s Portfolio TBRA Stock Details TBRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-144,542	Closed	-$5.74M	–	122
2016 Q3	$5.74M	Buy	+144,542	New	+$1.61M	0.61%	45

683 Capital Management's TBRA Position: Q4 2016 in Review

683 Capital Management sold out of Tobira Therapeutics, Inc. Common Stock (TBRA) in Q4 2016, closing a stake of 144,542 shares — an estimated $5.74M sold.

683 Capital Management first reported a position in TBRA in Q3 2016 and held it in 1 quarter. The position peaked at $5.74M in Q3 2016. 0 funds tracked by Wall St. Rank hold TBRA as of Q4 2016.

683 Capital Management reported no remaining Tobira Therapeutics, Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
683 Capital Management sold 144,542 Tobira Therapeutics, Inc. Common Stock shares in Q4 2016, an estimated $5.74M.
683 Capital Management first reported a position in Tobira Therapeutics, Inc. Common Stock in Q3 2016 and held it in 1 quarter.
683 Capital Management's Tobira Therapeutics, Inc. Common Stock position peaked at $5.74M in Q3 2016.
0 funds tracked by Wall St. Rank held Tobira Therapeutics, Inc. Common Stock as of Q4 2016.

Based on 683 Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.